Clinical Trials Logo

Clinical Trial Summary

This is an obstervationnal study, to evaluate the good clinical practice of the use of the sentinel node biospy in early stage endometrial cancer. The collaborating centres with the OncoGynecology board of the King Albert II Institute of the Clinique Universitaire Saint-Luc will also particpate to the trial.

Sentinel node biospy is not yet validated for endometrial cancer, even if lots of leading team in the world published very good result and that the first prospectives trials are already published with also excellents results. The investigators decided then to include this practice in their institutional guideslines and also to registred the procedure.


Clinical Trial Description

All the sentinel node biopsy procedures for endometrial cancer will be record online via the REDCap tools, securized on a servor in Saint-Luc. Automatic email for the following of the patients and the post operative event will be send regularly for every patient to the physicians who include the patient. Efficacy of the technique, False negative and postive rate, modifications of the adjuvant treatement, long terme evolution and complication wil be evaluate. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02545348
Study type Observational
Source Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Contact Mathieu LUYCKX
Phone 27649509
Email mathieu.luyckx@uclouvain.be
Status Recruiting
Phase
Start date August 2015
Completion date September 2020

See also
  Status Clinical Trial Phase
Completed NCT00377520 - A Trial for Patients With Advanced/Recurrent Endometrial Cancer Phase 2
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Completed NCT02387645 - LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma N/A
Recruiting NCT04438564 - Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients N/A
Recruiting NCT05742711 - Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients N/A
Suspended NCT06253494 - Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer Phase 1/Phase 2
Completed NCT04891146 - The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries
Recruiting NCT05273099 - Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma
Completed NCT05233059 - FitEx for Endometrial Cancer Survivors N/A
Recruiting NCT00726635 - The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies Phase 3
Completed NCT00859768 - The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients N/A